Skip to content

A prospective randomized controlled trial analyzing the clinical outcomes and patient satisfaction based on the implementation of the clinical pathway for Enhanced Recovery After Surgery program (ERAS CP) following oblique lumbar interbody fusion (OLIF)

A prospective randomized controlled trial analyzing the clinical outcomes and patient satisfaction based on the implementation of the clinical pathway for Enhanced Recovery After Surgery program (ERAS CP) following oblique lumbar interbody fusion (OLIF)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0009256
Enrollment
38
Registered
2024-03-20
Start date
2023-07-10
Completion date
Unknown
Last updated
2024-04-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Behavioral : For the ERAS group, a standardized clinical pathway that includes preoperative education, early postoperative ambulation, early oral feeding after surgery, and early discharge—components

Sponsors

Seoul National University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: A. Patients who are able to ambulate independently for more than 30 minutes (see below for specific screening details): i. Patients who, despite intermittent claudication, are able to reach a target distance of more than 30 minutes by taking breaks intermittently during ambulation are included. ii. Patients who are able to reach a target distance of more than 30 minutes despite experiencing severe pain are also included. B. Patients who visited the neurosurgery outpatient clinic for surgical treatment due to lumbar degenerative disease, requiring 1-2 segmental fixation between lumbar 2 and sacral 1. C. Patients who voluntarily agree to participate in the research

Exclusion criteria

Exclusion criteria: A. Patients who have previously undergone lumbar surgery. B. Patients with muscle weakness of Manual Muscle Testing grade 3 or higher. C. Patients with coexisting neuropsychiatric disorders, such as depression. D. Patients with musculoskeletal diseases (inflammatory, myopathic, etc.) and infections other than lumbar degenerative disease. E. Patients with concurrent malignant disease. F. Patients who do not wish to participate in the research

Design outcomes

Primary

MeasureTime frame
Numeric Rating Scale for back pain and leg pain

Secondary

MeasureTime frame
Numeric Rating Scale for back pain and leg pain;First ambulation time;First self-urination time;Total analgesic consumption;Patient satisfaction scale;Complication;30-day readmission;Medial cost (inhospital);Length of stay

Countries

Korea, Republic of

Contacts

Public ContactJun-Hoe Kim

Seoul National University Hospital

junhiya@snu.ac.kr+82-2-2072-3775

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026